1. The preoperative HbA1c level is an independent prognostic factor for the postoperative survival after resection of non-small cell lung cancer in elderly patients
    Makoto Motoishi et al, 2018, Surgery Today CrossRef
  2. Cancer Biology and Prevention in Diabetes
    Swayam Prakash Srivastava et al, 2020, Cells CrossRef
  3. Association of Diabetes Severity and Mortality with Lung Squamous Cell Carcinoma
    Chih-Hsiung Su et al, 2022, Cancers CrossRef
  4. Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxol-based Chemotherapy for Stage IV NSCLC
    Tomohiro Tamura et al, 2018, Clinical Lung Cancer CrossRef
  5. The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus
    Jie Qian et al, 2021, Frontiers in Oncology CrossRef
  6. Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a Monoclonal Antibody (SCTA01) Targeting SARS-CoV-2 in Healthy Adults: a Randomized, Double-Blind, Placebo-Controlled, Phase I Study
    Yinjuan Li et al, 2021, Antimicrobial Agents and Chemotherapy CrossRef
  7. Long‐term survival analysis of patients with non‐small cell lung cancer complicated with type 2 diabetes mellitus
    Gaoxiang Wang et al, 2020, Thoracic Cancer CrossRef
  8. Diabetes mellitus type 2 is associated with increased tumor expression of programmed death-ligand 1 (PD-L1) in surgically resected non-small cell lung cancer—A matched case-control study
    Christopher A. Febres-Aldana et al, 2020, Cancer Treatment and Research Communications CrossRef
  9. Impact of diabetes mellitus on postoperative outcomes in individuals with non-small-cell lung cancer: A retrospective cohort study
    Teruya Komatsu et al, 2020, PLOS ONE CrossRef
  10. Prognostic significance of preoperative haemoglobin A1c level in patients with lung adenocarcinoma
    Hiroyuki Ogawa et al, 2021, Interactive CardioVascular and Thoracic Surgery CrossRef
  11. Impact of Chronic Obstructive Pulmonary Disease on the Mortality of Patients with Small Cell Lung Cancer
    Kuang-Ming Liao et al, 2021, International Journal of Chronic Obstructive Pulmonary Disease CrossRef
  12. Mogroside V Inhibits Hyperglycemia-induced Lung Cancer Cells Metastasis through Reversing EMT and Damaging Cytoskeleton
    Jun Chen et al, 2019, Current Cancer Drug Targets CrossRef
  13. Clinicopathological and prognostic features of operable non‐small cell lung cancer patients with diabetes mellitus
    Kaoru Kaseda et al, 2021, Journal of Surgical Oncology CrossRef
  14. Prolonged progression-free survival and overall survival are associated with diabetes mellitus but inversely associated with levels of blood glucose in patients with lung cancer
    Ning-Fang Wang et al, 2020, Chinese Medical Journal CrossRef
  15. Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
    Ahmed Olatunde et al, 2021, Cancer Cell International CrossRef
  16. Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan
    Kaori Hisanaga et al, 2021, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy CrossRef
  17. Prognostic factors for resected non-small cell lung cancer in patients with type 2 diabetes mellitus
    Woo Sik Yu et al, 2018, Journal of Surgical Oncology CrossRef
  18. Patients with extra-adrenal malignancies and adrenal lesions have similar rates of subclinical hypercortisolism compared with patients with true adrenal incidentalomas
    Alexandra Chrisoulidou et al, 2019, Hormones CrossRef
  19. The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation
    Nick A. Iarrobino et al, 2018, Frontiers in Oncology CrossRef
  20. Effect of Metformin in Preventing Insulin-Mediated Proliferation of p53 and Liver Kinase B1 Mutant and Wild-Type Lung Cancer Cell Lines
    Manu Krishnan et al, 2018, Journal of Medical Academics CrossRef
  21. Metformin for lung cancer prevention and improved survival: a novel approach
    Juliana F. Roos et al, 2019, European Journal of Cancer Prevention CrossRef